Excerpt from Pseudotumor CerebriSynonyms, Key Words, and Related Terms: idiopathic intracranial hypertension, IIH, benign intracranial hypertension, pseudotumor cerebri, elevated intracranial pressure, ICP, papilledema, progressive optic atrophy, blindness, cerebral edema, occult cerebral venous outflow abnormalities, vision loss, vision impairment Please click here to view the full topic text: Pseudotumor CerebriBackgroundPseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH) is a disorder of unknown etiology. It affects predominantly obese women of childbearing age. The primary problem is chronically elevated intracranial pressure (ICP), and the most important neurologic manifestation is papilledema, which may lead to progressive optic atrophy and blindness. PathophysiologyA dominant early theory concerning the pathogenesis of elevated ICP in these patients was cerebral edema. Against this is the fact that no altered level of alertness, cognitive impairment, or focal neurological findings are associated with the elevated ICP. In addition, no pathologic signs of cerebral edema have been documented in these patients. Early reports describing edema were later considered to represent fixation artifact (ie, from tissue preparation) rather than in vivo edema. Current theories include increased resistance to cerebrospinal fluid (CSF) outflow at the arachnoid granulations that line the dural venous sinuses and through which CSF reabsorption is thought to occur by bulk flow. Alternatively, occult cerebral venous outflow abnormalities may produce IIH. Farb and colleagues have demonstrated that, in a series of 29 patients with IIH, narrowing of the transverse dural venous sinus was demonstrable on MR venography, while none of the 59 control subjects had this finding.1 These authors suggest that the narrowing is a consequence of elevated intracranial pressure, and, when the narrowing develops, it exacerbates the pressure elevation by increasing venous pressure in the superior sagittal sinus.
Bateman has shown that some patients with IIH with normal dural venous drainage have increased arterial inflow suggesting that collateral venous drainage occurs in addition to that provided by the superior sagittal sinus and transverse sinuses.2 The same investigator measured MR venography and MR flow quantification in cerebral arteries and veins in a series of 40 patients with IIH, of which 21 patients had venous stenosis. The arterial inflow was 21% higher than normal and superior sagittal sinus outflow was normal, resulting in reduced percentage of venous outflow compared to inflow. The remainder of arterial inflow volume is presumed to have drained via collateral venous channels. With clinical remission of symptoms, the arterial inflow volumes returned to normal.3 FrequencyUnited States
International
Mortality/Morbidity
RaceNo evidence exists to suggest predilection for any particular racial or ethnic group apart from variation in the prevalence of obesity in the different groups. Sex
AgePlease refer to the incidence statistics in Frequency. The highest incidence is among obese women of childbearing age. For most of the epidemiological series, this was women aged 15-44 years. Please click here to view the full topic text: Pseudotumor Cerebri |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |